Alterity Therapeutics Files 6-K, Notifies of Security Cessation
Ticker: PRNAF · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, securities-cessation
Related Tickers: ATH
TL;DR
Alterity Therapeutics filed a 6-K, nothing new but they're stopping ATH securities.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on September 3, 2024, to incorporate by reference into several of its existing SEC registration statements. The filing includes a notification of the cessation of securities for ATH.
Why It Matters
This filing is primarily administrative, incorporating previous documents into ongoing SEC filings, and signals a cessation of securities for ATH, which could impact investors.
Risk Assessment
Risk Level: low — The filing is administrative and incorporates existing documents, with the main event being a security cessation which is a factual notification.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ATH (company) — Security identifier
- September 3, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report information to the SEC and to be incorporated by reference into Alterity Therapeutics Limited's existing Registration Statements on Form S-8 and Form F-3.
What specific document is being submitted with this 6-K?
Exhibit 99.1, a Notification of cessation of securities - ATH, is being submitted with this 6-K.
Which SEC registration statements is this 6-K being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics Limited's Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office address is Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
What does the 'cessation of securities' for ATH signify?
The filing indicates a 'Notification of cessation of securities - ATH', suggesting that trading or the existence of these specific securities is being terminated or has ended.
Filing Stats: 191 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-09-03 06:03:38
Filing Documents
- ea0213163-6k_alterity.htm (6-K) — 13KB
- ea021316301ex99-1_alterity.htm (EX-99.1) — 31KB
- ex99-1_001.jpg (GRAPHIC) — 1KB
- 0001213900-24-074734.txt ( ) — 47KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Notification of cessation of securities - ATH 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: September 3, 2024 2